Form 483

Lawrence Berkeley National Laboratory IRB Form 483, 2017-09-21

FDA issued a Form 483 to Lawrence Berkeley National Laboratory IRB on 2017-09-21 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Lawrence Berkeley National Laboratory IRB · Berkeley, United States · Issued September 21, 2017

Overview

  • 6 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Sep 2017
21 CFR 361.1(c)(2)

Numerical votes not in the minutes of any RDRC meetings

Cited by Sandra S Saniga

21 Sep 2017
21 CFR 361.1(c)(3)

FDA research proposals not reported +30 subjects

Cited by Sandra S Saniga

21 Sep 2017
21 CFR 361.1(c)(2)

RDRC did not meet at least once each quarter

Cited by Sandra S Saniga

21 Sep 2017
21 CFR 361.1(c)(2)

Signatures of RDRC Chairman

Cited by Sandra S Saniga

21 Sep 2017
21 CFR 361.1(f)(1)

Packaging, labeling - Rx only

Cited by Sandra S Saniga

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 361.1(c)(2)Cited across public-safe Form 483 observations3x
21 CFR 361.1(c)(3)Cited across public-safe Form 483 observations1x
21 CFR 361.1(f)(1)Cited across public-safe Form 483 observations1x
21 CFR 361.1(f)(5)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere